個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
Genzyme: Engineering the Market for Orphan Drugs
內容大綱
Genzyme has made money with external technology in orphan drug markets generally considered to be too small to be attractive to other drug companies. Now competition is entering these same markets, placing Genzyme's business model under new pressures.